Default company panoramic image


Arthroventions™ develops technologies that enable more effective joint care.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Denver, CO, US
  • Currency USD
  • Founded January 2013
  • Employees 2
  • Website

Company Summary

Arthroventions™ is developing a family of devices that distends the synovial fluid from the joint space and guides the provider to more accurately place a needle into the synovial fluid. This device reduces patient pain and decreases the probability of a “dry tap” (missing the synovial space). Using our device any physician type can safely perform a joint tap as accurately as a specialist reducing the cost of joint care.


  • Default avatar
    Eric Hoffman
    Chief Executive Officer

    Eric Hoffman has 10 years’ experience in the pharmaceutical and medical device industries. Previously, he was a subject matter expert to the FDA and has worked with several biotech and pharmaceutical companies manufacturing and testing drugs and medical devices. His first start-up was in the craft brewing industry with Wild Goose Engineering. Eric recently left his position (Jan 15th) as a consultant to the FDA to focus 100% on Arthroventions.

  • Default avatar
    Dr. Richard Meehan
    Chief Scientific Officer

    Dr. Meehan is a co-founder and Chief Medical Officer of Arthroventions™. He is a rheumatologist and a Professor of Medicine at National Jewish Health. Dr. Meehan is a serial inventor and developed a retinal camera used aboard the Space Shuttle by NASA astronauts. Dr. Meehan was also a three-time Navy Battalion Surgeon and deployed to Afghanistan and Iraq.

  • Default avatar
    Elizabeth "Liz" Regan

    Dr. Regan is an assistant professor in the division of Rheumatology at National Jewish Health. She focuses on diseases and problems of the aging musculoskeletal system particularly arthritis, tendonitis and the aging athlete and the impact of reactive oxygen species and scavenging capacity on those conditions. Liz is also studying the genetics of chronic obstructive pulmonary disease.


  • Default avatar
    David Oppenheim of Miller and Law P.C.

Previous Investors

  • Default avatar
    National Jewish Health
    Default avatar
    State of Colorado - Bioscience Discovery Evaluation Grant